Analysts: This might be time for J&J to make an acquisition

03/5/2004 | Bloomberg Businessweek

The analysts point to the company's sagging stock price, a product of investor fear that Johnson & Johnson may not be able to maintain its 10% annual growth rate, as one reason the company needs to make an acquisition and get investors excited again. The analysts said the more likely targets would be in the specialty drug concerns, such as Cephalon, Allergan or Forest Labs, and St. Jude Medical on the medical device side of the industry.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Food & Beverage

Job Title Company Location
Culinary Arts Chef Instructor
The Culinary Institute of America
Singapore
Adjunct Instructor - Ancient Foods in the Modern World
The Culinary Institute of America
San Antonio, TX
Adjunct Instructor - Menu Development
The Culinary Institute of America
San Antonio, TX
Staff Assistant, Executive Sous Chef
University of Massachusetts Amherst
Amherst, MA